Mostrando 4 resultados de: 4
Filtros aplicados
Subtipo de publicación
Article(4)
Área temáticas
Farmacología y terapéutica(4)
Fisiología humana(3)
Temas específicos de historia natural de los animales(2)
Enfermedades(1)
Ginecología, obstetricia, pediatría, geriatría(1)
Objetivos de Desarrollo Sostenible
ODS 3: Salud y bienestar(4)
ODS 10: Reducción de las desigualdades(2)
ODS 12: Producción y consumo responsables(1)
ODS 5: Igualdad de género(1)
Origen
scopus(4)
A pharmacokinetic model of oral methylphenidate in the rat and effects on behavior
ArticleAbstract: Most animal studies using methylphenidate (MP) do not administer it the same way it is administeredPalabras claves:Attention Deficit Hyperactivity Disorder, Dopamine transporter, methylphenidate, Psychostimulant, ritalinAutores:Cooper T., David Edward Komatsu, Hadjiargyrou M., Hwang Y., Robison L.S., Steier J., Swanson J.M., Thanos P.K., Volkow N.D.Fuentes:scopusChronic exposure to methylphenidate impairs appendicular bone quality in young rats
ArticleAbstract: Methylphenidate (MP) is a psychostimulant widely prescribed to treat Attention Deficit HyperactivityPalabras claves:Biomechanics, DXA, Growth suppression, methylphenidate, TestosteroneAutores:Ananth M., David Edward Komatsu, Hadjiargyrou M., Janda H.A., John C.M., Mary M.N., Robison L.S., Swanson J.M., Thanos P.K., Volkow N.D.Fuentes:scopusCombined methylphenidate and fluoxetine treatment in adolescent rats significantly impairs weight gain with minimal effects on skeletal development
ArticleAbstract: Methylphenidate (MP) is frequently prescribed to treat Attention-Deficit/Hyperactivity Disorder (ADHPalabras claves:Fluoxetine, methylphenidate, RAT, Skeletal developmentAutores:Areikat N., Chirokikh A.A., Connor C., David Edward Komatsu, Duque E., Hadjiargyrou M., Jones R., Thanos P.K., Uddin S.M.Z.Fuentes:scopusSex differences in the physiological and behavioral effects of chronic oral methylphenidate treatment in rats
ArticleAbstract: Methylphenidate (MP) is a psychostimulant prescribed for Attention Deficit Hyperactivity Disorder. PPalabras claves:Attention Deficit Hyperactivity Disorder, methylphenidate, Psychostimulant, ritalin, Sensitization, Sex differencesAutores:David Edward Komatsu, Fricke D., Gandhi J., Hadjiargyrou M., Lam C., Lee J., Mauceri A., Miao E., Michaelos M., Paeng S., Robison L.S., Thanos P.K., Vitale M.Fuentes:scopus